An image of a smartphone and a pen
Markets

Pfizer’s Adjusted Q2 Net Beats View; Forecast Reiterated (PFE)

Drugmaker Pfizer Inc. ( PFE ) on Tuesday posted a 5% gain in second quarter profits despite a drop in revenue, beating analyst expectations.

The New York-based company reported second quarter net income of $2.61 billion, or 33 cents per share, compared with $2.48 billion, or 31 cents per share, in the year-ago period. Excluding one-time items, adjusted profit was 60 cents per share.

Revenue fell 1% from last year to $16.98 billion.

On average, Wall Street analysts expected a smaller profit of 59 cents per share, albeit on higher revenue of $17.02 billion.

Looking ahead, the company maintained its full-year profit outlook for $2.16 to $2.26 per share on an adjusted basis, while analysts expected $2.25 per share for the year.

Pfizer shares fell 16 cents, or -0.8%, in premarket trading Tuesday.

The Bottom Line

We have been recommending shares of Pfizer ( PFE ) since Mar.17, 2011, when the stock was trading at $19.30. The company has a 4.21% dividend yield, based on last night's closing stock price of $19.01.

Pfizer Inc. ( PFE ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.6 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PFE

Other Topics

Stocks

Latest Markets Videos